University of Pennsylvania

Name

University of Pennsylvania

Legal name

The Trustees of the University of Pennsylvania

Website

https://upenn.edu

Company type

Private

Founded year

1740

Operating status

Operating

Headcount range

5,001–10,000 employees

Ownership category

akta.pro rank

Product category

Higher Education

NAICS

Colleges, Universities, and Professional Schools (6113), Colleges, Universities, and Professional Schools (61131)

SIC

Services-Educational Services (8200), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA)

akta.pro secondary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

Keywords

• Higher education services
• Medical research programs
• Graduate professional studies
• Translational medicine research
• Academic medical center

Headquarters

HQ city

Philadelphia

HQ country

United States

HQ region

North America

Offices7 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Tuition and Fees: Tuition revenue from undergraduate and graduate programs; 2026-27 total cost of attendance $94,582 with 3.9% tuition increase
2. Research Grants and Contracts: Federal and private research funding from agencies including NSF, NIH, DARPA, supporting nine research centers and training programs
3. Endowment Investment Returns: University endowment of $24.8 billion generating investment returns; $20.5B grew to $24.8B since 2021 net-zero commitment
4. Philanthropic Donations: Major gifts supporting research and facilities including $55M from Blackstone's Gray for cancer prevention and $50M for autism research
5. Healthcare Services (Penn Medicine): Penn Medicine operating profit of $189M in first half fiscal 2026, with $6.76B total revenue from clinical services

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

The University of Pennsylvania is a private Ivy League research university that delivers undergraduate, graduate, and professional education across 12 schools, conducts federally and privately funded research spanning life sciences, engineering, AI, photonics, and humanities, and operates Penn Medicine—an integrated academic health system providing clinical care that translates laboratory discoveries into patient treatments. The Penn Center for Innovation commercializes research outputs through startup formation, licensing, and industry partnerships.

Product overview

The University of Pennsylvania is an academic research institution that does not offer commercial products or services in the traditional SaaS sense. Instead, it conducts research across multiple disciplines including life sciences, engineering, medicine, and technology. The institution has launched strategic initiatives such as the $200 million Penn Engineering Futures Fund to support early-stage research in human health, sustainable infrastructure, and physical intelligence.

Differentiator

Problem solved

Functional benefit

Brands

• Penn Medicine: University of Pennsylvania Health System providing healthcare services and medical research
• Penn Engineering
• Penn Vet
• Wharton School

Products and services

• Undergraduate Education Programs Bachelor's degree programs across Penn's 12 schools including the College of Arts and Sciences, Penn Engineering, Wharton Undergraduate, and Penn Nursing, with 4.9% acceptance rate for fall 2025 and $347M allocated to financial aid.
• Graduate and Professional Education Master's, doctoral, MD, JD, MBA and other professional degree programs across Wharton School, Penn Law, Penn Medicine, Penn Engineering, and graduate arts and sciences, with over 3,700 graduate workers represented by GETUP-UAW.
• Penn Medicine Healthcare Services Integrated academic medical center delivering clinical care through hospitals, outpatient clinics, and specialty centers across Pennsylvania and New Jersey, including gene therapy and CAR-T cell therapy treatments; $6.76B revenue in first half fiscal 2026.
• Penn Center for Innovation Technology Transfer Technology transfer and commercialization services supporting 330+ startups and securing $1.2B+ in sponsored research, licensing Penn-developed gene therapies, CAR-T treatments, lipid nanoparticle platforms, and other research outputs.
• Penn Global and Study Abroad Programs International academic programs including Penn Abroad with the PASSPORT platform, Perry World House foreign policy engagement, and global initiatives connecting Penn students with international research and learning opportunities.
• Penn Online Learning Online education programs and digital learning platforms extending Penn's academic offerings to remote learners and working professionals.
• Penn Institute for Translational Medicine World's first institute for translational medicine, launched in 2005 to convert scientific discoveries into practical clinical applications, providing infrastructure for translational research and commercialization.
• Penn Athletics Program Intercollegiate athletics programs competing in Ivy League and conference sports, with facilities including Franklin Field, supporting student-athletes across multiple NCAA Division I sports.

Quantifiable outcome

• 10-year durable remissions in 36%+ of large B-cell lymphoma patients treated with CAR-T therapy
• +6 more outcomes

Named customers3 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability10 records

Feature9 records

Partnerships

14 partnerships are on record, tiered minor, strategic and core.

• CurePSPminorStrategic or Co-development Partner · 22 June 2026CurePSP CARES grant program awarding $155,000 to four research projects at seven medical institutions including Penn, focused on progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy
• Greystar Real Estate PartnersstrategicStrategic or Co-development Partner · 3 June 2026Greystar and Penn closed on 493-bed graduate housing redevelopment project at Sansom Place West, with construction underway and completion targeted for 2027-28. Project is Greystar's first student housing investment through infrastructure platform.
• U.S. Food and Drug Administration (FDA)coreStrategic or Co-development Partner · 28 April 2026FDA launched real-time clinical trial initiative with Penn Medicine participating in TRAVERSE Phase 2 trial for mantle cell lymphoma and MD Anderson partnership. FDA Commissioner Marty Makary announced initiative allowing regulators to monitor trial endpoints as they occur through cloud-based systems.
• Pomelo CarestrategicStrategic or Co-development Partner · 12 March 2026Pomelo Care published peer-reviewed research in collaboration with Penn's Leonard Davis Institute of Health Economics analyzing administrative claims data from nearly 45,000 deliveries. Studies found 24.4% reduction in preterm births and 26%+ reduction in NICU length of stay with virtual maternity care.
• Service to School (S2S) VetLink ProgramcoreStrategic or Co-development Partner · 11 March 2026Penn announced partnership with Service to School nonprofit to expand undergraduate admissions access for military veterans and service members, offering free application counseling, mentoring, and networking. Initiative addresses low veteran enrollment (4.9% acceptance rate, only 5 veterans in traditional undergrad program, 268 total across programs). Partnership in development for about six months.
• NovartiscoreStrategic or Co-development PartnerStrategic partnership with Novartis resulted in FDA-approved CAR T therapy Kymriah; exemplifies Penn's shift from traditional patenting toward collaborative innovation models
• BioNTechcoreStrategic or Co-development PartnerPartnership with BioNTech on mRNA technologies, leveraging Penn research capabilities in gene therapy and immunotherapy
• Liberate BiostrategicStrategic or Co-development PartnerLiberate Bio secured exclusive and non-exclusive licenses to Penn's myeloid-optimized CAR design patents for advancing in vivo CAR-M therapies, combining with proprietary lipid nanoparticle delivery and RAPTOR screening platform
• Children's Hospital of Philadelphia (CHOP)coreStrategic or Co-development PartnerPenn Medicine's partner in multiple breakthrough research initiatives including gene therapy (Luxturna), CAR T therapies, and ARPA-H maternal health project OMEGA; CHOP spinout Spark Therapeutics manufactures Luxturna
• University of Pennsylvania Thoracic Surgery DepartmentminorStrategic or Co-development PartnerPenn's thoracic surgery department partnering with AiraLux Medical startup on small-scale clinical trial for gamified digital incentive spirometer targeting post-surgical patient compliance
• MD Anderson Cancer CentercoreStrategic or Co-development PartnerMD Anderson partnering with Penn and FDA on TRAVERSE Phase 2 real-time clinical trial for mantle cell lymphoma as part of FDA initiative to modernize drug development
• Keystone AI + Quantum Factory ConsortiumstrategicStrategic or Co-development PartnerPennsylvania's seven research-intensive universities including Penn, Carnegie Mellon, Pitt, Penn State, Drexel, Temple, and Lehigh joined Pittsburgh Supercomputing Center and Team Pennsylvania in statewide innovation network focused on AI and quantum computing research translation
• UPMC Magee Womens Hospital, University of Pittsburgh, Notre Dame, Washington University, Institute of Photonic Sciences (Spain), Tyndall National Institute (Ireland)strategicStrategic or Co-development PartnerNine-member team on ARPA-H OMEGA project for wearable fetal monitoring during labor; Carnegie Mellon leading $39.3M contract for direct fetal oxygen delivery assessment technology
• IsometricstrategicStrategic or Co-development PartnerJennifer Wilcox, Penn Presidential Distinguished Professor, serves as Chief Scientist at Isometric carbon removal company while conducting research on carbon capture policy and science at Energy Solutions Forum

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Harvard University: America's oldest higher-education institution and Ivy League peer with comparable scale, $50B+ endowment, world-leading medical school, and similar translational research output. Direct competitor for faculty, students, and federal research funding.
• Massachusetts Institute of Technology: Elite private research university with leading engineering, AI, and biotech programs, a comparable $20B+ endowment, and similar translational commercialization engine. Competes directly for STEM talent, federal grants, and startup formation.
• Stanford University: Private research university with comparable scale, Silicon Valley-adjacent commercialization engine, and leading medical school. Direct competitor for translational research funding, biotech spinouts, and elite graduate students.
• Yale University: Ivy League research university with parallel graduate/professional school structure, large endowment, and similar research-intensive model. Competes with Penn across law, medicine, and sciences.
• Columbia University: Ivy League research university in a major US metro area with comparable medical center scale, similar endowment size, and overlapping research areas including translational medicine and engineering.
• Princeton University: Ivy League peer competing for the same undergraduate applicant pool with similarly elite brand, comparable endowment per student, and overlapping strengths in sciences and engineering.
• Johns Hopkins University: Private research university with the largest US academic medical research enterprise, parallel biomedical commercialization focus, and similar federal funding profile. Closest direct peer to Penn in translational medicine scale.
• Cornell University: Ivy League research university with parallel land-grant-adjacent research scope, comparable engineering and life sciences programs, and similar federal research funding mix.
• Duke University: Private research university with strong medical center and engineering school, similar endowment magnitude, and analogous translational research and commercialization activity. Competes with Penn for biomedical talent and partnerships.
• New York University: Major private research university with a large medical center (NYU Langone), substantial research portfolio, and similar urban footprint. Competes for graduate students, medical faculty, and federal research dollars.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/Penn
• YouTubeyoutube.com/user/univpennsylvania
• Facebookfacebook.com/UnivPennsylvania
• LinkedInlinkedin.com/company/university-of-pennsylvania
• Instagraminstagram.com/uofpenn

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries5 records

Funding overview

Funding rounds8 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments15 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about University of Pennsylvania